NASDAQ:ARPO
Delisted

Aerpio Pharmaceuticals Stock News

etoro logo Buy ARPO
*Your capital is at risk
$13.14
-0.370 (-2.74%)
At Close: Aug 17, 2022
May 03, 2020 (CDN Newswire via Comtex) -- A recent comprehensive study titled Global Macular Edema Therapeutics Market 2020 by Company, Regions, Type and...

New Strong Buy Stocks for April 24th

11:24am, Friday, 24'th Apr 2020
New Strong Buy Stocks for April 24th

New Strong Buy Stocks For April 20th

02:46pm, Monday, 20'th Apr 2020
New Strong Buy Stocks For April 20th

New Strong Buy Stocks For April 20th

02:46pm, Monday, 20'th Apr 2020
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
If you're interested in Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), then you might want to consider its beta (a...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IntelGenx Technologies (IGXT), Aerpio Pharmaceuticals
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on IntelGenx Technologies ( IGXT – Research Report ), Aerpio Pharmaceuticals ( ARPO – Research Report
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...
Plan to advance AKB-9778 topical formulation into a Phase 2 trial in open angle glaucoma with top line results expected during the first quarter of 2021 Conference Call and.
Plan to advance AKB-9778 topical formulation into a Phase 2 trial in open angle glaucoma with top line results expected during the first quarter of 2021 ...
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conferenc
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either. Biogen Inc (NASDAQ: BIIB) was in the news for all wrong...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE